H
Heather Clouting
Researcher at University College London
Publications - 3
Citations - 684
Heather Clouting is an academic researcher from University College London. The author has contributed to research in topics: Medicine & Ethambutol. The author has an hindex of 3, co-authored 3 publications receiving 340 citations.
Papers
More filters
Journal ArticleDOI
High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis
Amina Jindani,Thomas S. Harrison,Andrew J. Nunn,Patrick P. J. Phillips,Gavin J. Churchyard,Salome Charalambous,Mark Hatherill,Hennie Geldenhuys,Helen McIlleron,Simbarashe P. Zvada,Stanley Mungofa,Nasir A. Shah,Simukai Zizhou,Lloyd Magweta,James Shepherd,Sambayawo Nyirenda,Janneke H. van Dijk,Heather Clouting,David Coleman,Anna L.E. Bateson,Timothy D. McHugh,Philip D. Butcher,Denny A. Mitchison +22 more
TL;DR: The 6-month regimen that included weekly administration of high-dose rifapentine and moxifloxacin was as effective as the control regimen and the 4- month regimen was not noninferior to thecontrol regimen.
Journal ArticleDOI
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
Hana M. El Sahly,Lindsey R. Baden,Brandon Essink,Susanne Doblecki-Lewis,Judith M. Martin,Evan J. Anderson,Thomas B. Campbell,Jesse L. Clark,Lisa A. Jackson,Carl J. Fichtenbaum,Marcus J. Zervos,Bruce Rankin,Frank Eder,Gregory Feldman,Christina Kennelly,Laurie Han-Conrad,Michael Levin,Kathleen M. Neuzil,Lawrence Corey,Peter B. Gilbert,Holly Janes,Dean Follmann,Mary A. Marovich,Laura Polakowski,John R. Mascola,Julie E. Ledgerwood,Barney S. Graham,Allison August,Heather Clouting,Weiping Deng,Shu Han,Brett Leav,Deb Manzo,Rolando Pajon,Florian Schödel,Joanne E Tomassini,Honghong Zhou,Jacqueline M. Miller +37 more
TL;DR: The mRNA-1273 vaccine showed 94.1% efficacy in preventing coronavirus disease 2019 (Covid-... as discussed by the authors ) in a phase 3, observer-blinded, placebo-controlled clinical trial.
Posted ContentDOI
Covid-19 in the Phase 3 Trial of mRNA-1273 During the Delta-variant Surge
Lindsey R. Baden,Hana M. El-Sahly,Brandon Essink,Dean Follman,Kathleen M. Neuzil,Allison August,Heather Clouting,Gabrielle Fortier,Weiping Deng,Shu Han,Xiaoping Zhao,Brett Leav,Carla Talarico,Bethany Girard,Yamuna Paila,Joanne E Tomassini,Florian Schödel,Rolando Pajon,Honghong Zhou,Rituparna Das,Jacqueline Miller +20 more
TL;DR: In this paper, the authors evaluated the incidence and genetic sequences of Covid-19 cases in the ongoing COVE trial during the open-label phase, with a focus on July-August 2021, when delta-variants surged in the US.